Elyxium Wealth, LLC
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 2043538
BEVERLY HILLS, CA
Position in VRTX
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$366,088
+$72,714 QoQ
Shares Held
737
+12.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#1,169
of 1,735 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 1%
Shared 0%
None 99%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Elyxium Wealth, LLC holds $2,843,263 across 2 Biotechnology names. VRTX ranks #2 (12.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
8,229 | $2,477,175 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
737 | $366,088 |
All Filings in VRTX
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $366,088 | 737 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $293,374 | 657 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $257,505 | 568 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $204,434 | 522 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $239,961 | 539 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $211,380 | 436 | Shares | Other | 2025-05-05 | |
| No filing history on record for this holder in this stock. | ||||||